Related references
Note: Only part of the references are listed.Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study
Paolo Denti et al.
CLINICAL INFECTIOUS DISEASES (2022)
Longitudinal evidence on treatment discontinuation, adherence, and loss of hypertension control in four middle-income countries
Nicole Mauer et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
A polypill improves secondary prevention of heart attack
H. Vaillant et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)
Polypill Strategy in Secondary Cardiovascular Prevention
Jose M. Castellano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity
Sohini Mandal et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2021)
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update
Patrick F. van Rheenen et al.
JOURNAL OF CROHNS & COLITIS (2021)
Polypill with or without Aspirin in Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Strategies to simplify complex medication regimens
J Simon Bell et al.
Australian Journal of General Practice (2021)
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine
Malvika Verma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment
Malvika Verma et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Long-Term Survival after Acute Myocardial Infarction in Lithuania during Transitional Period (1996-2015): Data from Population-Based Kaunas Ischemic Heart Disease Register
Ricardas Radisauskas et al.
MEDICINA-LITHUANIA (2019)
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial
Gholamreza Roshandel et al.
LANCET (2019)
Polypill for Cardiovascular Disease Prevention in an Underserved Population
Daniel Munoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A once-a-month oral contraceptive
Ameya R. Kirtane et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study
Kendra K. Radtke et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
Ameya R. Kirtane et al.
NATURE COMMUNICATIONS (2018)
Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form
David H. Altreuter et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Eva M. Lonn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals
Andrew M. Bellinger et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial
M. Lafeber et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
3D printing of tablets containing multiple drugs with defined release profiles
Shaban A. Khaled et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles
Shaban A. Khaled et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease
Frances Wood et al.
BMJ OPEN (2015)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care
Vanessa Selak et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD The UMPIRE Randomized Clinical Trial
Simon Thom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Dosing Frequency and Medication Adherence in Chronic Disease
Craig I. Coleman et al.
JOURNAL OF MANAGED CARE PHARMACY (2012)
Polypharmacy: one of the greatest prescribing challenges in general practice
Rupert A. Payne et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2011)
Ethambutol Analysis by Copper Complexation in Pharmaceutical Formulations: Spectrophotometry and Crystal Structure
Adriana F. Faria et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2011)
An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (Polypill) in People with Raised Cardiovascular Risk
Anthony Rodgers et al.
PLOS ONE (2011)
A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
Elsayed Z. Soliman et al.
TRIALS (2011)
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
Hueiming Liu et al.
BMC PUBLIC HEALTH (2010)
Potentially inappropriate prescribing and cost outcomes for older people: a national population study
Caitriona Cahir et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial
S. Yusuf et al.
LANCET (2009)
The Triple Aim: Care, health, and cost
Donald M. Berwick et al.
HEALTH AFFAIRS (2008)
Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease - The heart and soul study
Anil K. Gehi et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
A strategy to reduce cardiovascular disease by more than 80%
NJ Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
